WideCells Group PLC (WDC) launched July 2012 making cord blood banking more accessible through insurance coverage, and increasing the availability of cord blood for transplants.

FT article (link below) says:
There’s even a very young UK entrant into the market, called WideCells Group, which listed late last year on the main market of the London Stock Exchange, with a market cap of £7.5m. Headed by the very young, articulate and energetic João Andrade, it boasts well-known City investors on its register including Miton.

This very early-stage, Manchester-based business has its own, very British take on the stem cell sector, focusing on our national heritage in insurance and education. As well as its own putative blood bank, it has developed an insurance product called Cell Plan which is in effect a healthcare plan for less than £15 a month.
FT.com article
https://www.ft.com/content/d082ed08-3cb4-11e7-ac89-b01cc67cfeec

Stockopedia says: Adventurous, Micro Cap, Momentum Trap.
It qualifies for 2 key short selling screens Altman Z-Score and James Montier 'Unholy Trinity'.

A chinese version seems to be thriving....
China Cord Blood
CO $9.9 1.0 11.4% 3:10pm
Adventurous, Mid Cap,

Finish reading with a 14 day trial

or Unlock with your email

Already have an account?
Login here